Global HEOR Strategy Lead — Payer & HTA (Hybrid)

UCB S.A.

Reading

Hybrid

GBP 90,000 - 140,000

Full time

12 days ago

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Benefits offered by this job

Hybrid work model (40% office)

Job summary

UCB S.A. is seeking a Health Economic & Outcomes Research Strategy Lead to shape global HEOR strategies and payer evidence across the product lifecycle.

You will influence development programs and collaborate with cross-functional teams to support successful payer access and reimbursement decisions. The role offers hybrid work arrangements with 40% office time, and opportunities to contribute to value dossiers, publication activities, and international collaboration across markets including the

Qualifications

  • Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or a related field.
  • At least 8 years of experience within the pharmaceutical industry, including consultancy experience where relevant.
  • Strong expertise in health economic modelling, outcomes research, and payer evidence generation.
  • Experience supporting HTA submissions, reimbursement strategies, and access initiatives across key markets.
  • Experience working in global or matrix organizations, with above-country or intercontinental exposure highly valued.
  • Strong leadership, communication, stakeholder management, and strategic thinking skills.

Responsibilities

  • Develop and execute global HEOR strategies aligned with HTA and payer evidence requirements across the product lifecycle.
  • Design and deliver HEOR evidence generation activities, including cost-effectiveness models, budget impact models, systematic literature reviews, and quality-of-life research.
  • Develop asset value assessments and support economically justified pricing and value strategies.
  • Build and communicate economic value stories for assets and indications.
  • Influence clinical development programs to ensure evidence generation plans address payer and EU HTA needs.
  • Represent HTA and payer perspectives within cross-functional teams.

Skills

HEOR strategy
Health economics modelling
Payer evidence generation
Leadership
Stakeholder management
Strategic thinking

Education

Master's degree or PhD in Health Economics or related

Job description

UCB S.A. is seeking a Health Economic & Outcomes Research Strategy Lead to shape global HEOR strategies and payer evidence across the product lifecycle.

You will influence development programs and collaborate with cross-functional teams to support successful payer access and reimbursement decisions. The role offers hybrid work arrangements with 40% office time, and opportunities to contribute to value dossiers, publication activities, and international collaboration across markets including the

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Global HEOR Strategy Lead: Payer Evidence & Access
Global HEOR Strategy Lead: Payer Evidence & Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Senior HEOR Expert: Global Value & Access
Senior HEOR Expert: Global Value & Access

UCB S.A. • Princes Risborough

Hybrid
GBP 70,000 - 100,000
Health Economics Lead - Payer Value Strategy
Health Economics Lead - Payer Value Strategy

UCB • Slough

Hybrid
GBP 65,000 - 90,000
Senior HEOR Expert – Rare Disease, Global Access
Senior HEOR Expert – Rare Disease, Global Access

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Princes Risborough

On-site
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB • Slough

Hybrid
GBP 90,000 - 130,000
Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A. • Slough

Hybrid
GBP 90,000 - 130,000
Hybrid work model
Global exposure
Global HEOR Lead: Evidence & Market Access Strategy
Global HEOR Lead: Evidence & Market Access Strategy

Grünenthal Group • Maidenhead

On-site
GBP 80,000 - 120,000
Hybrid HEOR Associate Director — Payer & Outcomes Strategy
Hybrid HEOR Associate Director — Payer & Outcomes Strategy

BioMarin Pharmaceutical Inc. • Greater London

Hybrid
GBP 90,000 - 120,000